AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant increase in stockholder equity and that the Company has entered into Amendment #2 to its existing ...
AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced a significant increase in stockholder equity and that the Company has entered ...
He is a committed ideologue and a partisan brawler who’s worked out how to hide those traits from the general public.
HUNTSVILLE, May 14, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ...
Phase 1b Registrational Clinical Study of SER-252 Underway in Advanced Parkinson's Disease; TFL data from the SAD study arm targeted for first half of 2027 - - Closed $21.2 million private placement ...
From RF-based sensing to AI video intelligence and autonomous flight— a planned build-out in a sector being reshaped by AI procurementNEW YORK, ...
Thursday, May 14, 2026 at 10 a.m. ET Chief Executive Officer — Gary Atkinson Chief Financial Officer — Alex Andre Revenue -- ...
Cosmetology schools receive federal funds and report to the state, but in Pennsylvania, most complaints aren’t publicly ...
Q1 2026 Earnings Call May 14, 2026 10:00 AM EDTCompany ParticipantsGary Atkinson - CEO, Secretary & ChairmanAlex ...
Veru Inc. (NASDAQ: VERU) Q2 2026 Earnings Call Transcript May 13, 2026 Veru Inc. beats earnings expectations. Reported EPS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results